Literature DB >> 22571578

Necrobiotic xanthogranuloma: response to chlorambucil.

Emma Ryan1, Lachlan J Warren, Ferenc Szabo.   

Abstract

This report of necrobiotic xanthogranuloma associated with chronic lymphocytic leukaemia describes the response of skin lesions to chlorambucil. Characteristic clinical and histological features of necrobiotic xanthogranuloma are presented, as well as a discussion regarding management and the use of chlorambucil.
© 2010 The Authors. Australasian Journal of Dermatology © 2010 The Australasian College of Dermatologists.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 22571578     DOI： 10.1111/j.1440-0960.2010.00710.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


  4 in total

1.  A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.

Authors:  Caroline A Nelson; Connie S Zhong; David A Hashemi; Hovik J Ashchyan; Zoe Brown-Joel; Megan H Noe; Sotonye Imadojemu; Robert G Micheletti; Ruth Ann Vleugels; Karolyn A Wanat; Misha Rosenbach; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

2.  Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma.

Authors:  Marlies Wruhs; Robert Feldmann; Isabelle Sawetz; Friedrich Breier; Andreas Steiner
Journal:  Case Rep Dermatol       Date:  2016-12-01

Review 3.  Cutaneous manifestations of monoclonal gammopathy.

Authors:  Jean-Sebastien Claveau; David A Wetter; Shaji Kumar
Journal:  Blood Cancer J       Date:  2022-04-11       Impact factor: 11.037

Review 4.  Systemic therapy of necrobiotic xanthogranuloma: a systematic review.

Authors:  Lisa Steinhelfer; Thomas Kühnel; Herbert Jägle; Stephanie Mayer; Sigrid Karrer; Frank Haubner; Stephan Schreml
Journal:  Orphanet J Rare Dis       Date:  2022-03-24       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.